Last reviewed · How we verify

NCT04969393

Effects of High Intensity Laser on Mechanical and Physiological Findings in Pregnant Women With Carpal Tunnel Syndrome

Completed NA Last updated 9 September 2021
What this trial tests

NA trial testing High intensity laser therapy in Carpal Tunnel Syndrome in 54 participants. Completed in 30 July 2021.

Timeline
30 April 2021
Primary endpoint
30 July 2021
30 July 2021

Quick facts

Lead sponsorOctober 6 University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment54
Start date30 April 2021
Primary completion30 July 2021
Estimated completion30 July 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

October 6 University

Who can join

Adults 20 to 40, any sex, with Carpal Tunnel Syndrome or Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will propose a novel approach to treat pregnant women with mild to moderate carpal tunnel syndrome (CTS) using the recently introduced High intensity laser therapy with its deep penetration and high-power characteristics. It's hopeful that the results of this study can fill the gap of knowledge surrounding the conservative treatment options for CTS in order to help patients restore their nerve function properly and promote new ways of addressing CTS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of High intensity laser therapy

Trials testing the same drug.

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other October 6 University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04969393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing